Warby Parker shows strong price momentum with a technical breakout above all major moving averages and rising volume accumulation, but the stock has already reached its analyst target with negative remaining upside, high short interest of 14%, and a below-average overall score of 4.5 limiting conviction.
Thesis pillars
- Strong Breakout Momentum↓Deteriorating
- Excellent Cash Conversion→Stable
- Target Reached Negative Asymmetry↓Deteriorating
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 26, 2026· older than 90 days
Warby Parker Inc. (WRBY) Stock Analysis
Falling Knife setup
Healthcare · Medical Instruments & Supplies
Sell if holding. Engine safety override at $21.94: Risk below floor (2.2 < 2.5) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10 and A.R:R 1.8:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 24%; Elevated put/call ratio: 37.98; Below-average business quality.
Warby Parker designs and sells prescription eyeglasses, sunglasses, contact lenses, and eye care services through 323 U.S. retail stores and digital commerce, with frames starting at $95. Contact lenses contributed 11.1% and eye exams 6.4% of 2025 net revenue; the company... Read more
Sell if holding. Engine safety override at $21.94: Risk below floor (2.2 < 2.5) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10 and A.R:R 1.8:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 24%; Elevated put/call ratio: 37.98; Below-average business quality. Chart setup: Death cross, below all MAs, RSI 32, MACD bearish. Score 5.2/10, moderate confidence.
Passes 6/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 0d<=7d. Suitability: aggressive.
About Warby Parker Inc.
About Warby Parker Inc.
Warby Parker operated 323 U.S. retail stores at December 31, 2025, selling eyeglasses, contact lenses (11.1% of 2025 net revenue), and eye exams and vision care (6.4% of 2025 net revenue), with all eyewear regulated by the U.S. FDA as a medical device. The company employed 4,036 people and sold frames starting at $95 in a U.S. eyewear market the Vision Council estimated at $70 billion as of December 2025. Insurance-backed purchases were only 8.3% of 2025 revenue despite insurance covering roughly 60% of industry-wide U.S. vision care purchases.
Warby Parker generates revenue through direct-to-consumer sales of prescription eyewear, contacts, and eye care services across 323 stores and its e-commerce platform. The company designs eyewear in-house at its New York City headquarters and manufactures through a network of more than 30 partners spanning frame factories, lens suppliers, and distribution centers across China, Japan, Vietnam, Italy, and Thailand, with in-house optical labs in Sloatsburg, New York, and Las Vegas, Nevada. The filing flags dependence on a limited number of frame and lens suppliers and reliance on Amazon Web Services for technology infrastructure. Competing against vertically integrated players EssilorLuxottica and VSP (which own frame brands, lens networks, and vision insurance plans) as well as low-priced online rival Zenni Optical, Warby Parker remains underpenetrated in insurance-backed purchases relative to the broader category. Progressive lenses represented 22.3% of prescription units at December 31, 2025, compared with approximately 40% industry-wide, indicating an underpenetrated premium-lens category.
Show full overview
Warby Parker sources frames and lenses from a network of more than 30 manufacturing partners located most notably in China, Japan, Vietnam, Italy, and Thailand, with the Risk Factors Summary explicitly flagging dependence on a limited number of suppliers and contract manufacturers. A loss of any of these partners could negatively affect the business, per the filing. The company also relies on Amazon Web Services for its entire technology infrastructure; the 10-K states that any disruption of or interference with that service could adversely affect business, financial condition, or operations — a single-platform dependency without a named alternative cloud provider.
See also: Healthcare · Medical Instruments & Supplies
From Warby Parker Inc.'s most recent 10-K filing, extracted June 16, 2026.
Recent developments
updated Nov 1, 2026Recent Developments — Warby Parker Inc.
Latest news
- NEWS Could Warby Parker (NYSE:WRBY) Transform Eyewear With Google? - Kalkine Media — Kalkine Media Nov 1, 2026 positive
- NEWS WRBY Q3'26 Earnings: revenue estimate is 245.06M USD - TradingView — TradingView Oct 29, 2026 neutral
- NEWS Warby Parker stock price target reiterated at $34 by BTIG - Investing.com — Investing.com Oct 27, 2026 neutral
- NEWS Warby Parker (WRBY) Ticks Higher to $25.91 as Buyers Defend Support - Double EMA - https://www.siam.in/ — https://www.siam.in/ Oct 25, 2026 neutral
- NEWS What To Expect From Warby Parker’s (WRBY) Q2 Earnings - StockStory — StockStory Aug 5, 2026 neutral
Latest item Nov 1, 2026 · Generated 2026-11-04T11:59:37Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMSupplierlimited number of suppliers10-K Item 1A: 'We face risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.'
- MEDIUMSupplierAmazon Web Services10-K Item 1A: 'Our business relies on Amazon Web Services'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Volatile — 6.5% daily ATR makes tight stops impractical. Position-size conservatively.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $21.94: Risk below floor (2.2 < 2.5) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10 and A.R:R 1.8:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 24%; Elevated put/call ratio: 37.98; Below-average business quality. Chart setup: Death cross, below all MAs, RSI 32, MACD bearish. Prior stop was $20.94. Score 5.2/10, moderate confidence.
Analyst target: $26.97 (+22.9% upside). Prior stop was $20.94. Stop-loss: $20.94.
Risk below floor (2.2 < 2.5).
Warby Parker Inc. trades at a P/E of 365.7 (forward 35.7). TrendMatrix value score: 7.4/10. Verdict: Sell.
21 analysts rate WRBY, with a consensus score of 4.0/5. 12 analysts publish price targets averaging $31.
What does Warby Parker Inc. do?Warby Parker designs and sells prescription eyeglasses, sunglasses, contact lenses, and eye care services through 323...
Warby Parker designs and sells prescription eyeglasses, sunglasses, contact lenses, and eye care services through 323 U.S. retail stores and digital commerce, with frames starting at $95. Contact lenses contributed 11.1% and eye exams 6.4% of 2025 net revenue; the company competes against EssilorLuxottica and VSP in a U.S. eyewear market estimated at $70 billion.